Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析

◆英語タイトル:Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1651
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sunesis Pharmaceuticals Inc (SNSS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company’s pipeline products include Vecabrutinib (SNS-062) for the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies; SSN-510 for the treatment of hematology and solid tumors. The company partnered programs under development include TAK-580 (formerly MLN2480) and Vosaroxin for the treatment of various types of cancer. The company focuses on license and collaboration arrangements with other companies to expand its internal development capabilities and also has direct operations through its subsidiaries in the UK and Malta. Sunesis is headquartered in South San Francisco, California, the US.

Sunesis Pharmaceuticals Inc Key Recent Developments

Mar 10,2020 Sunesis Pharmaceuticals reports fourth quarter and full-year 2019 financial results and recent highlights
Nov 12,2019 Sunesis Pharmaceuticals reports third quarter 2019 financial results and recent highlights
Sep 19,2019 Sunesis Pharmaceuticals appoints Dr. Nicole Onetto to the Board of Directors
Aug 07,2019 Sunesis Pharmaceuticals reports second quarter 2019 financial results and recent highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sunesis Pharmaceuticals Inc – Key Facts
Sunesis Pharmaceuticals Inc – Key Employees
Sunesis Pharmaceuticals Inc – Key Employee Biographies
Sunesis Pharmaceuticals Inc – Major Products and Services
Sunesis Pharmaceuticals Inc – History
Sunesis Pharmaceuticals Inc – Company Statement
Sunesis Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sunesis Pharmaceuticals Inc – Business Description
Sunesis Pharmaceuticals Inc – Corporate Strategy
Sunesis Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Sunesis Pharmaceuticals Inc – Strengths
Sunesis Pharmaceuticals Inc – Weaknesses
Sunesis Pharmaceuticals Inc – Opportunities
Sunesis Pharmaceuticals Inc – Threats
Sunesis Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sunesis Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 10, 2020: Sunesis Pharmaceuticals reports fourth quarter and full-year 2019 financial results and recent highlights
Nov 12, 2019: Sunesis Pharmaceuticals reports third quarter 2019 financial results and recent highlights
Sep 19, 2019: Sunesis Pharmaceuticals appoints Dr. Nicole Onetto to the Board of Directors
Aug 07, 2019: Sunesis Pharmaceuticals reports second quarter 2019 financial results and recent highlights
May 08, 2019: Sunesis Pharmaceuticals reports first quarter 2019 financial results and recent highlights
Mar 07, 2019: Sunesis Pharmaceuticals reports fourth quarter and full-year 2018 financial results and recent highlights
Jan 17, 2019: Sunesis announces Proposed Public Offering of Common Stock and Preferred Stock
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sunesis Pharmaceuticals Inc, Key Facts
Sunesis Pharmaceuticals Inc, Key Employees
Sunesis Pharmaceuticals Inc, Key Employee Biographies
Sunesis Pharmaceuticals Inc, Major Products and Services
Sunesis Pharmaceuticals Inc, History
Sunesis Pharmaceuticals Inc, Subsidiaries
Sunesis Pharmaceuticals Inc, Key Competitors
Sunesis Pharmaceuticals Inc, Ratios based on current share price
Sunesis Pharmaceuticals Inc, Annual Ratios
Sunesis Pharmaceuticals Inc, Annual Ratios (Cont...1)
Sunesis Pharmaceuticals Inc, Interim Ratios
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sunesis Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sunesis Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Sunesis Pharmaceuticals Inc, Ratio Charts
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Range Resources Ltd (RRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Resources Ltd (Range Resources) is an independent upstream oil and gas company. It explores, develops and produces oil and gas in Georgia, Guatemala and Trinidad. The company works on both onshore and offshore production and its onshore projects are operational through water injection. …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Anglo American Plc:企業のM&A・事業提携・投資動向
    Anglo American Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo American Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • United Bank Of India:企業の戦略・SWOT・財務分析
    United Bank Of India - Strategy, SWOT and Corporate Finance Report Summary United Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tetra Technologies, Inc.
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Acome:企業の戦略・SWOT・財務情報
    Acome - Strategy, SWOT and Corporate Finance Report Summary Acome - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • AVEVA Group Plc:企業の戦略・SWOT・財務情報
    AVEVA Group Plc - Strategy, SWOT and Corporate Finance Report Summary AVEVA Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Amphastar Pharmaceuticals Inc (AMPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s product …
  • Michael J Fox Foundation for Parkinson’s Research-医療機器分野:企業M&A・提携分析
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities in the area of Parkinson's diseas …
  • Alligator Bioscience AB (ATORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Alligator Bioscience AB (Alligator Bioscience) is a clinical-stage biotechnology company that discovers and develops antibody based pharmaceuticals for the treatment of cancer. The company’s pipeline products include ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527. The ADC-1013, currently und …
  • Spinneys Dubai LLC:企業の戦略・SWOT・財務分析
    Spinneys Dubai LLC - Strategy, SWOT and Corporate Finance Report Summary Spinneys Dubai LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Chunghwa Telecom Co., Ltd.:企業の戦略・SWOT・財務情報
    Chunghwa Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chunghwa Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pakistan Petroleum Limited (PPL)-石油・ガス分野:企業M&A・提携分析
    Summary Pakistan Petroleum Limited (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company produces crude oil, natural gas, natural gas liquids, liquefied petroleum gas and barytes. It operates producing fields in Sui, Kandhkot, A …
  • Orkla ASA:企業の戦略・SWOT・財務情報
    Orkla ASA - Strategy, SWOT and Corporate Finance Report Summary Orkla ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Grifols SA (GRF):製薬・医療:M&Aディール及び事業提携情報
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • ID Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy, and other bio products. It offers vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s ve …
  • Arsenal Holdings plc:企業の戦略的SWOT分析
    Arsenal Holdings plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆